Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Clinical trial NCT05727839 · COMPLETED
Trial details
- NCT number
- NCT05727839
- Sponsor
- Immorna Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-24
- Primary completion
- 2024-09-30
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.